Luke Hesson received his B.S. degree in medical science (BMedSc) from the Medical School, University of Birmingham, UK in 2001 and a Ph.D. degree in clinical genetics from the Department of Medical and Molecular Genetics, University of Birmingham, graduating in 2005. In 2005, he was awarded the Breast Cancer Campaign UK Team of the Year 2004 Prize with 3 other colleagues at the House of Lords. This was followed by an MRC Career Development Fellowship (2005–2007) at the MRC Protein Phophorylation Unit, University of Dundee, with the world renowned biochemist Professor Sir Philip Cohen. Following this, Hesson returned to The University of Birmingham to continue post-doctural research (2007– 2009). Currently, he holds the position of Team Leader of the Molecular and Cellular Oncology Laboratory, Adult Cancer Program, Lowy Cancer Research Centre (UNSW) and Lecturer at UNSW. He is also an Active Member of the American Association for Cancer Research and is a Cancer Institute New South Wales Fellow. Dr. Hesson has published extensively in leading cancer research journals and has made significant contributions to the fields of cancer epigenetics and the identification and functional analysis of tumour suppressor genes. His current research focuses are on genome-wide analyses of the genetic and epigenetic features of colorectal cancer using next generation sequencing technologies.
Biography Updated on 29 August 2011